Just Healthcare

Just Healthcare

Most GLP-1 Prescriptions Miss the Mark in Obesity Treatment

New recommendations stress muscle preservation, micronutrient monitoring, and long-term planning for effective GLP-1 therapy

Naveen Sankar S's avatar
Naveen Sankar S
Jul 29, 2025
∙ Paid
2
1
Share
Generated image

While GLP-1 receptor agonists like semaglutide offer substantial weight loss and metabolic benefits, new guidance emphasizes that long-term success requires structured follow-up, attention to muscle mass and nutrition, and a relapse prevention plan.

Study Details

GLP-1 receptor agonists including semaglutide and tirzepatide have gained prominence in obesi…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture